Newcastle University
Newcastle University is recorded as a service provider in 4 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 4 of 4 trials · Latest update first
A Cancer Research UK Phase II trial of CY-101 given via intratumoural administration in locally advanced or metastatic adrenocortical carcinoma (CLARITY)
Sponsor Cancer Research UK
- Start (EU)
- Latest update
- Estimated end
BEACON2: A multi-arm multi-stage platform trial for relapsed neuroblastoma
Sponsor The University Of Birmingham
- Start (EU)
- Latest update
- Estimated end
CompARE: Phase III randomised controlled trial Comparing Alternative Regimens for escalating treatment of intermediate and high-risk oropharyngeal cancer
Sponsor The University Of Birmingham
- Start (EU)
- Latest update
- Estimated end
Myechild 01: International Randomised Phase III Clinical Trial in Children with Acute Myeloid Leukaemia - Incorporating an Embedded Dose Finding Study for Gemtuzumab Ozogamicin in Combination with Induction Chemotherapy
Sponsor The University Of Birmingham
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Newcastle University?
The 2026-10-09 snapshot links Newcastle University to 4 distinct CTIS trials. Recorded services include Laboratory services, Analysis and Data Analysis, HPV testing to confirm eligibility. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Newcastle University?
The most frequently recorded therapeutic areas are Solid Tumor Oncology, Endocrinology. Recorded phases include Phase 2, Phase 1, Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Newcastle University conducted?
The linked trials record locations in 11 countries, including France, Germany, Spain, Ireland, Norway. These are trial locations, not confirmed office locations or countries where Newcastle University delivered services.
What can this page tell me about Newcastle University's trial experience?
Browse 4 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Newcastle University. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Newcastle University